Paper37664153
Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
Zhang MH and 8 others. World J Gastroenterol, 2023. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. Papers, record 37664153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37664153
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Hepatitis B | Major topic |
| Humans | |
| Hepatitis B virus | |
| Prognosis | |
| Biomarkers |
Source PubMed
References230
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30805015 | MicroRNA-325-3p inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma by down-regulation of aquaporin 5. | Cell Mol Biol Lett | 2019 | https://conductscience.org/library/papers/30805015 | PubMed |
| 2 | 35196550 | HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation. | Ann Hepatol | 2022 | https://conductscience.org/library/papers/35196550 | PubMed |
| 3 | 33995383 | The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. | Front Immunol | 2021 | https://conductscience.org/library/papers/33995383 | PubMed |
| 4 | 31695788 | HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. | Theranostics | 2019 | https://conductscience.org/library/papers/31695788 | PubMed |
| 5 | 32346400 | Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker. | Gut Pathog | 2020 | https://conductscience.org/library/papers/32346400 | PubMed |
| 6 | 35101942 | Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. | J Immunother Cancer | 2022 | https://conductscience.org/library/papers/35101942 | PubMed |
| 7 | 24732044 | MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. | Oncogenesis | 2014 | https://conductscience.org/library/papers/24732044 | PubMed |
| 8 | 34978008 | Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis. | Cell Biol Toxicol | 2023 | https://conductscience.org/library/papers/34978008 | PubMed |
| 9 | 24971953 | Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. | Cancer Biol Ther | 2014 | https://conductscience.org/library/papers/24971953 | PubMed |
| 10 | 31574452 | LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling. | Mol Immunol | 2019 | https://conductscience.org/library/papers/31574452 | PubMed |
| 11 | 28846110 | Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA. | Oncogene | 2017 | https://conductscience.org/library/papers/28846110 | PubMed |
| 12 | 22105822 | Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/22105822 | PubMed |
| 13 | 27317768 | Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27317768 | PubMed |
| 14 | 23200856 | Specific miRNA stabilization by Gld2-catalyzed monoadenylation. | Cell Rep | 2012 | https://conductscience.org/library/papers/23200856 | PubMed |
| 15 | 17188425 | Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. | Cancer Lett | 2007 | https://conductscience.org/library/papers/17188425 | PubMed |
| 16 | 30633901 | Biological Functions of Autophagy Genes: A Disease Perspective. | Cell | 2019 | https://conductscience.org/library/papers/30633901 | PubMed |
| 17 | 20736804 | Receiver operating characteristic curve in diagnostic test assessment. | J Thorac Oncol | 2010 | https://conductscience.org/library/papers/20736804 | PubMed |
| 18 | 24462768 | MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. | Biochem Biophys Res Commun | 2014 | https://conductscience.org/library/papers/24462768 | PubMed |
| 19 | 34583064 | Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro. | Clin Res Hepatol Gastroenterol | 2022 | https://conductscience.org/library/papers/34583064 | PubMed |
| 20 | 17662943 | Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by dicer-1. | Cell | 2007 | https://conductscience.org/library/papers/17662943 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42365459 | Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA-Based Single and Combined Biomarkers. | Can J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42365459 | PubMed |
| 42062626 | HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/42062626 | PubMed |
| 41645267 | miR-194-5p targets SOCS2 to predict pegIFNα treatment response in HBeAg-positive chronic hepatitis B patients. | Virol J | 2026 | https://conductscience.org/library/papers/41645267 | PubMed |
| 41318560 | miR-223-3p predicts prognosis of hepatitis B virus-related acute-on-chronic liver failure and is involved in hepatocyte injury via HSP90B1. | Hereditas | 2025 | https://conductscience.org/library/papers/41318560 | PubMed |
| 41232091 | Serum exosomal miR-1275 as a potential biomarker for the diagnosis and prognostic assessment of hepatocellular carcinoma. | Cancer Biomark | 2025 | https://conductscience.org/library/papers/41232091 | PubMed |
| 40901642 | Identification of Key Gene Related to Matrisome in HBV-Associated Liver Cirrhosis via Bioinformatics Analysis. | Int J Hepatol | 2025 | https://conductscience.org/library/papers/40901642 | PubMed |
| 40416872 | Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/40416872 | PubMed |
| 39847120 | The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/39847120 | PubMed |
| 39829957 | Targeting microRNA methylation: Innovative approaches to diagnosing and treating hepatocellular carcinoma. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39829957 | PubMed |
| 39472817 | A narrative review: exploring viral-induced malignancies through the lens of dysregulated cellular metabolism and glucose transporters. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39472817 | PubMed |
| 39100497 | Current updates on the molecular and genetic signals as diagnostic and therapeutic targets for hepatitis B virus-associated hepatic malignancy. | Heliyon | 2024 | https://conductscience.org/library/papers/39100497 | PubMed |
| 38565755 | miR-3188 inhibits hepatitis B virus transcription by targeting Bcl-2. | Arch Virol | 2024 | https://conductscience.org/library/papers/38565755 | PubMed |
| 38464387 | The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. | Explor Target Antitumor Ther | 2024 | https://conductscience.org/library/papers/38464387 | PubMed |
Genes200
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37664153
GET https://conductscience.org/api/papers/v1/37664153/references?page=2